Showing results (101-110 of 217) with videos related to
Sort By:
Pageof 22
Journal of the American Society of Nephrology : JASN|August 31, 2000
Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formationToshio Miyata, Yasuhiko Ueda, Koichi Asahi, et al.Journal of the American Society of Nephrology : JASN|October 21, 2005
Renoprotective properties of angiotensin receptor blockers beyond blood pressure loweringYuko Izuhara, Masaomi Nangaku, Reiko Inagi, et al.Plos One|June 4, 2016
Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse ModelBo Yeong Jeong, Md Jamal Uddin, Jong Hee Park, et al.Cell Death Discovery|March 27, 2026
Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibitionAbd Aziz Ibrahim, Hiromi Miura, Tomoya Terada, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 1, 2007
Carbonyl stress reduction in peritoneal dialysis fluid: development of a novel high-affinity adsorption beadMakoto Yamamoto, Yuko Izuhara, Takatoshi Kakuta, et al.Journal of the American Society of Nephrology : JASN|December 1, 2001
Cloning and characterization of a novel subunit of protein serine/threonine phosphatase 4 from mesangial cellsTakehiko Wada, Toshio Miyata, Reiko Inagi, et al.Antioxidants (Basel, Switzerland)|April 30, 2021
Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification DeficitsShin Koike, Kazuya Toriumi, Sakura Kasahara, et al.Hypertension (Dallas, Tex. : 1979)|July 21, 2010
Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressureSusumu Ogawa, Keisuke Nakayama, Masaaki Nakayama, et al.International Journal of Molecular Sciences|April 28, 2018
Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 OverexpressionSuzan Wetzels, Kristiaan Wouters, Toshio Miyata, et al.Drug Metabolism and Pharmacokinetics|April 29, 2018
Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese populationMasahiro Hiratsuka, Noriyasu Hirasawa, Yoshiteru Oshima, et al.Pageof 22